Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,767.60
(
-1.51%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.70
(
1.99%
)
Bitcoin
70,785.01
(
-0.64%
)
News Focus
News Focus
Post# of 30493
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: old man post# 157

Tuesday, 06/30/2009 6:50:32 PM

Tuesday, June 30, 2009 6:50:32 PM

Post# of 30493

[OT] MNTA: But I will remember MNTA, HES, Vale if and when funds are available.

I just posted an update on MNTA’s 2009-2010 news flow in #msg-39156766.

Unlike most biotech stocks that are awaiting a regulatory decision by the FDA, MNTA cannot be “timed” because FDA reviews of generic drugs do not have formal deadlines. In other words, FDA action on the Lovenox ANDA—the primary driver for MNTA’s share price—could come at any time.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up